Designing Small-Molecule Allosteric Inhibitors of CYP2C19 to Prevent Clopidogrel Resistance in Patients With Specific Genetic Polymorphisms. LMJHCR [Internet]. 2025 Dec. 31 [cited 2026 Feb. 19];3(2):e76. Available from: https://linkmjhcr.com/index.php/lmj/article/view/76